Paper4091785
Influence of dipyridamole on infarct size and on cardiac nucleoside content following coronary occlusion in the dog.
Matsuoka H and 2 others. Basic Res Cardiol, 1985. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Influence of dipyridamole on infarct size and on cardiac nucleoside content following coronary occlusion in the dog. Papers, record 4091785. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4091785
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Influence of dipyridamole on infarct size and on cardiac nucleoside content following coronary occlusion in the dog.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine | Major topic |
| Dipyridamole | Major topic |
| Myocardial Infarction | Major topic |
| Animals | |
| Chromatography, High Pressure Liquid | |
| Coronary Disease | |
| Dogs | |
| Female | |
| Hemodynamics | |
| Inosine | |
| Male | |
| Myocardium | |
| Phosphocreatine |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6254686 | The role of adenosine in the regulation of coronary blood flow. | Circ Res | 1980 | https://conductscience.org/library/papers/6254686 | PubMed |
| 2 | 13628477 | [Pharmacological properties of a new coronary dilator substance 2, 6-bis(diethanolamino)-4, 8-dipiperidino-pyrimido[5,4-d]pyrimidine]. | Arzneimittelforschung | 1959 | https://conductscience.org/library/papers/13628477 | PubMed |
| 3 | 6604525 | The control of adenosine concentration in polymorphonuclear leucocytes, cultured heart cells and isolated perfused heart from the rat. | Biochem J | 1983 | https://conductscience.org/library/papers/6604525 | PubMed |
| 4 | 5520352 | Influence of dipyridamol (Persantin) on myocardial adenosine metabolism. | J Mol Cell Cardiol | 1970 | https://conductscience.org/library/papers/5520352 | PubMed |
| 5 | 5541108 | Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation. | Circ Res | 1971 | https://conductscience.org/library/papers/5541108 | PubMed |
| 6 | 5347963 | Uptake and deamination of adenosine by blood. Species differences, effect of pH, ions, temperature and metabolic inhibitors. | Biochim Biophys Acta | 1969 | https://conductscience.org/library/papers/5347963 | PubMed |
| 7 | 7285306 | Salvage of ischemic myocardium by dipyridamole in the conscious dog. | Circulation | 1981 | https://conductscience.org/library/papers/7285306 | PubMed |
| 8 | 1168469 | Adenosine uptake by erythrocytes of man, rat and guinea-pig and its inhibition by hexobendine and dipyridamole. | Biochem Pharmacol | 1975 | https://conductscience.org/library/papers/1168469 | PubMed |
| 9 | 5782714 | Potentiation of adenosine activity by low oral doses of lidoflazine. | Nature | 1969 | https://conductscience.org/library/papers/5782714 | PubMed |
| 10 | 7124399 | The prophylactic effect of dipyridamole on the size of myocardial infarction following coronary artery occlusion. | Acta Pathol Microbiol Immunol Scand A | 1982 | https://conductscience.org/library/papers/7124399 | PubMed |
| 11 | 7351049 | Effectiveness of dipyridamole in reducing the size of experimental myocardial infarction. | Circulation | 1980 | https://conductscience.org/library/papers/7351049 | PubMed |
| 12 | 4606569 | Functional significance of the coronary collateral circulation. A review. | Am J Pathol | 1974 | https://conductscience.org/library/papers/4606569 | PubMed |
| 13 | 632362 | A comparison of four potential agents for reducing necrosis after prolonged coronary occlusion. | J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/632362 | PubMed |
| 14 | 475727 | Experimental occlusion of two small coronary arteries in the same heart. A new validation method for infarct size manipulation. | Basic Res Cardiol | 1979 | https://conductscience.org/library/papers/475727 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 30744423 | Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue. | J Cardiovasc Pharmacol Ther | 2019 | https://conductscience.org/library/papers/30744423 | PubMed |
| 9546646 | Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes. | Mol Cell Biochem | 1998 | https://conductscience.org/library/papers/9546646 | PubMed |
| 2770708 | Inhibitors of adenosine catabolism improve recovery of dog myocardium after ischemia. | Mol Cell Biochem | 1989 | https://conductscience.org/library/papers/2770708 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4091785
GET https://conductscience.org/api/papers/v1/4091785/authors